Description

Oxaceprol Sustained Release Tablets 600 mg – OXAPRIL 600 SR

Description
OXAPRIL 600 SR is a formulation of Oxaceprol Sustained Release Tablets 600 mg, helps in the management of osteoarthritis and joint-related disorders. Oxaceprol is a hydroxyproline derivative that provides anti-inflammatory and chondroprotective effects by inhibiting leukocyte migration and supporting cartilage matrix integrity. The SR formulation ensures consistent plasma levels throughout the day, providing prolonged relief with improved patient compliance.

Key Points
Chondroprotective Action — Oxaceprol protects cartilage tissue by inhibiting the degradation of collagen and proteoglycans, slowing the progression of joint damage.

Anti-Inflammatory Effect — Reduces joint inflammation by inhibiting leukocyte and monocyte migration to the affected site, without the gastric side effects associated with conventional NSAIDs.

Sustained Release Advantage — The SR matrix ensures controlled drug delivery over 24 hours, maintaining therapeutic plasma levels and reducing dosing frequency.

Improved Joint Mobility — Provides effective relief from joint pain, stiffness, and swelling, restoring functional mobility and quality of life.

Better GI Tolerability — Unlike traditional NSAIDs, Oxaceprol does not inhibit prostaglandin synthesis, making it safer for long-term use in elderly patients.

Targeted Specialties
Orthopedics & Joint Disorders
Rheumatology
Geriatric Care
General Medicine & Pain Management

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.